The over diagnosis of diffuse mesothelioma: An analysis of 311 cases with recommendations for the avoidance of pitfalls

Ann Diagn Pathol. 2024 Feb:68:152248. doi: 10.1016/j.anndiagpath.2023.152248. Epub 2023 Dec 21.

Abstract

Background: The diagnosis of mesothelioma may be challenging. We investigated a large database of cases in order to determine the frequency with which a diagnosis of mesothelioma was made incorrectly and the most frequent causes of error.

Design: A database including more than 4000 consultation cases of histologically confirmed mesothelioma was examined to identify cases in which mesothelioma was diagnosed by at least one pathologist when the available information pointed towards a different diagnosis.

Results: There were 311 cases misdiagnosed as mesothelioma. The most common category was metastatic carcinoma to the pleura or peritoneum (129 cases: 73 lung carcinomas, 15 renal cell carcinomas). The next most common category was primary lung cancer (111 cases: 55 sarcomatoid carcinoma, 56 pseudomesotheliomatous carcinoma). The third most common category was primary malignancies arising from or near the serosal membranes (33 cases). The fourth most common category was fibrous pleurisy (38 cases). The most common errors were failure to consider important radiographic information regarding the gross distribution of tumor, lack of awareness or consideration of another malignancy, overreliance on certain immunohistochemical results, and failure to perform certain diagnostic histochemical, immunohistochemical, or ultrastructural studies.

Conclusions: There are a number of diagnostic pitfalls that can lead to the over diagnosis of mesothelioma. Careful attention to clinical and radiographic information as well as performance of appropriate ancillary tests can help to prevent such misdiagnoses. Detailed examples will be presented to assist in the avoidance of these pitfalls with emphasis on the most commonly observed errors.

Keywords: Differential diagnosis; Diffuse mesothelioma; Pleural metastases; Serosal membrane tumors.

MeSH terms

  • Biomarkers, Tumor / analysis
  • Carcinoma* / pathology
  • Diagnosis, Differential
  • Humans
  • Lung Neoplasms* / diagnosis
  • Lung Neoplasms* / pathology
  • Mesothelioma* / diagnosis
  • Mesothelioma* / pathology
  • Mesothelioma, Malignant* / diagnosis
  • Overdiagnosis
  • Pleural Neoplasms* / diagnosis
  • Pleural Neoplasms* / metabolism
  • Pleural Neoplasms* / pathology

Substances

  • Biomarkers, Tumor